Advertisement

Rural Caregivers’ Willingness for Community Pharmacists to Administer the HPV Vaccine to Their Age-Eligible Children

  • Alexis M. KoskanEmail author
  • Lauren N. Dominick
  • Deborah L Helitzer
Article
  • 35 Downloads

Abstract

Human papillomavirus (HPV) vaccination uptake varies by geographic regions with rural, often medically underserved areas, lagging behind more urban regions in terms of vaccine initiation and completion. In these regions, pharmacies may serve as an additional location for HPV vaccine administration. Little is known about rural caregivers’ willingness to have their HPV vaccine age-eligible children obtain this vaccine from their local pharmacist. First and second authors conducted 26 in-depth interviews with caregivers of HPV vaccine age-eligible children living in rural regions of a southwestern state to explore their perceptions of the HPV vaccine and their willingness for pharmacist-administered HPV vaccination. They analyzed interview data using an inductive qualitative content analyses approach. The majority of caregivers were unaware that pharmacists could offer adolescent vaccines. However, most were willing to allow their children to receive the vaccine from this non-traditional source. Comments related to obtaining vaccinations from pharmacists related mostly to concerns about proper training and their certification to vaccinate against HPV. Caregivers believed that having a pharmacist administer the HPV vaccine would not affect their relationship with their primary care provider. Caregivers preferred print health education resources and were interested in also receiving health information via social media to learn more about the HPV vaccine and pharmacists’ role in HPV vaccine administration. Pharmacies may serve as an additional site to increase HPV vaccine initiation and completion. Rural regions need additional health information about the HPV vaccine and pharmacists’ abilities to administer this cancer prevention resource.

Keywords

Human papillomavirus HPV vaccine Primary care Pharmacy Rural 

Notes

Compliance with Ethical Standards

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Arizona State University Institutional Review Board, STUDY00006995) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C (2015) US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 107(6):djv086CrossRefGoogle Scholar
  2. 2.
    Zahnd W, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L (2017) Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomark Prev 27:1265–1274CrossRefGoogle Scholar
  3. 3.
    Centers for Disease Control and Prevention (2014) CDC grand rounds: reducing the burden of HPV-associated cancer and disease. Morb Mortal Wkly Rep 63(4):69–72Google Scholar
  4. 4.
    Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Azurah AGNF, Siew M (2016) Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. JAMA 316(22):2411–2421CrossRefGoogle Scholar
  5. 5.
    Meites E (2016) Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 65(49):1405–1408CrossRefGoogle Scholar
  6. 6.
    Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams C, Meyer S, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. Morb Mortal Wkly Rep 66(33):874–882CrossRefGoogle Scholar
  7. 7.
    Mohammed KA, Subramaniam DS, Geneus CH, Henderson ER, Dean CA, Subramaniam DP, Burroughs TE (2018) Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med 109:39–43CrossRefGoogle Scholar
  8. 8.
    Boyd ED, Phillips JM, Schoenberger YM, Simpson (2018) Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine 36(28):4126–4133CrossRefGoogle Scholar
  9. 9.
    Mills LA, Head KJ, Vanderpool RC (2013) HPV vaccination among young adult women: a perspective from Appalachian Kentucky. Prev Chronic Dis 10:E17CrossRefGoogle Scholar
  10. 10.
    Carhart MY, Schminkey DL, Mitchella EM, Keim-Malpass J (2018) Barriers and facilitators to improving Virginia’s HPV vaccination rate: a stakeholder analysis with implications for pediatric nurses. J Pediatr Nurs 42:1–8CrossRefGoogle Scholar
  11. 11.
    Getrich CM, Broidy LM, Kleymann E, Helitzer DL, Kong AS, Sussman AL (2014) Different models of HPV vaccine decision-making among adolescent girls, parents, and health-care clinicians in New Mexico. Ethn Health 19(1):47–63CrossRefGoogle Scholar
  12. 12.
    Sussman AL, Helitzer D, Bennet A, Solares A, Lanoue M, Getrich C (2015) Catching up with the HPV vaccine: challenges and opportunities in primary care. Ann Fam Med 13(4):354–360CrossRefGoogle Scholar
  13. 13.
    Kepka D, Spigarelli MG, Warner EL, Yoneoka Y, McConnell N, Balch A (2016) Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data. Papillomavirus Res 2:128–132CrossRefGoogle Scholar
  14. 14.
    Katz IT, Bogart LM, Fu CM, Liu Y, Cox JE, Samuels RC, Chase T, Schubert P, Schuster MA (2016) Barriers to HPV immunization among blacks and latinos: a qualitative analysis of caregivers, adolescents, and providers. BMC Public Health 16(1):874CrossRefGoogle Scholar
  15. 15.
    Mclean HQ, Birchmeier B, Chow B, Vickrs E, McNeil M, Gee J, Stokley S, Belongia E, Vanwormer J (2016) Health care provider attitudes and barriers regarding human papillomavirus (HPV) vaccination: factors associated with increasing HPV vaccine coverage before and after an intervention program. Open Forum Infect Dis 3(suppl 1):718CrossRefGoogle Scholar
  16. 16.
    Preciado M, Hudson SM, Rondinelli J, Glenn BA, Chao C (2015) An in-depth interview study of immunization providers to understand practice patterns, barriers and facilitators for administering the 3-dose HPV vaccine series. J Patient Cent Res Rev 2(2):90–91CrossRefGoogle Scholar
  17. 17.
    US Department of Health and Human Services (2014) Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel, National Cancer Institute, Editor. 2014: Bethesda, MD. Accessed from https://deainfo.nci.nih.gov/advisory/pcp/annualreports/hpv/PDF/PCP_Annual_Report_2012-2013.pdf
  18. 18.
    Fava JP, Colleran J, Bignasci F, Cha R, Kilgore (2017) Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood. Hum Vaccin ImmunotherGoogle Scholar
  19. 19.
    Nichols K, Girotto J, Mitchell-Van Steele A, Stofella S (2017) Duty to advocate: human papillomavirus vaccination. J Pediatr Pharmacol Ther 22(1):74–76Google Scholar
  20. 20.
    Gallup (2018) Honesty/ethics in professions. Accessed from https://news.gallup.com/poll/1654/honesty-ethics-professions.aspx
  21. 21.
    National Association of Chain Drug Stores, 2010–2011 chain pharmacy industry profile. 2010, NACDS: Alexandria, VAGoogle Scholar
  22. 22.
    Hohmeier KC, Randolph DD, Smith CT, Hagemann TM (2016) A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting. SAGE Open Med 4:1–5CrossRefGoogle Scholar
  23. 23.
    Goad J, Bach A (2015) The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integr Pharm Res Pract 4:67–77Google Scholar
  24. 24.
    Shah PD, Trogdon JG, Golden SD, Golin CE, Marciniak MW, Brewer NT (2018) Impact of pharmacists on access to vaccine providers: a geospatial analysis. Milbank Q 96(3):568–592CrossRefGoogle Scholar
  25. 25.
    McIntosh J, Sturpe D, Khanna N (2008) Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists. J Am Pharm Assoc 48(1):e1–e16CrossRefGoogle Scholar
  26. 26.
    Rothholz M, Tan L (2017) Promoting the immunization neighborhood: benefits and challenges of pharmacies as additional locations for HPV vaccination. Hum Vaccin Immunother 13(8):1856–1858CrossRefGoogle Scholar
  27. 27.
    Kuper A, Reeves S, Levinson W (2008) An introduction to reading and appraising qualitative research. BMJ 337(7666):404–407Google Scholar
  28. 28.
    Lombard M, Snyder-Duch J, Bracken CC (2010) Practical resources for assessing and reporting intercoder reliability in content analysis research projects. Accessed from http://matthewlombard.com/reliability/index_print.html#What%20is%20intercoder%20reliability Google Scholar
  29. 29.
    Sutton J, Austin Z (2015) Qualitative research: data collection, analysis, and management. Can J Hop Pharm 68(3):226–231Google Scholar
  30. 30.
    Ando H, Cousins R, Young C (2014) Achieving saturation in thematic analysis: development and refinement of a codebook. Compr Psychol 3:4CrossRefGoogle Scholar
  31. 31.
    Islam JY, Gruber JF, Lockhart A, Kunwar M, Wilson S, Smith SB, Brewer NT, Smith JS (2017) Opportunities and challenges of adolescent and adult vaccination administration within pharmacies in the United States. Biomed Inform Insights 9:1178222617692538CrossRefGoogle Scholar
  32. 32.
    Shah P, Calo WA, Marciniak MW, Gilkey MB, Brewer N (2018) Support for pharmacist-provided HPV vaccination: national surveys of US physicians and parents. Cancer Epidemiol Biomark Prev 27(8):970–978CrossRefGoogle Scholar
  33. 33.
    Arizona State Legislature, A.S., 32-1974. Pharmacists’ administration of immunizations, vaccines and emergency medications; certification; reporting requirements; advisory committee; definitions. 2007. Accessed from https://www.azleg.gov/viewDocument/?docName=http://www.azleg.gov/ars/32/01974.htm
  34. 34.
    Swiecki-Sikora AL, Henry KA, Kepka D (2019) HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health.  https://doi.org/10.1111/jrh.12353
  35. 35.
    Goad JA, Taitel MS, Fensterheim LE, Cannon AE (2013) Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med 11(5):429–436CrossRefGoogle Scholar
  36. 36.
    Rock C, de Barra E, Sadlier C, Kelly S, Dowling C, McNally C, Bergin C (2013) Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort. J Infect Public Health 6(3):173–178CrossRefGoogle Scholar
  37. 37.
    Van Dyne EA, Jnley SJ, Saraiya M, Thomas CC, Markowtiz LE, Benard VB (2018) Trends in human papillomavirus–associated cancers—United States, 1999–2015. Morb Mortal Wkly Rep 67(33):918–924CrossRefGoogle Scholar
  38. 38.
    DeStefano F, Bodenstab HM, Offit PA (2019) Principal controversies in vaccine safety in the United States. Clin Infect Dis ciz135, https://doi-org.ezproxy1.lib.asu.edu/10.1093/cid/ciz135
  39. 39.
    Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis R, Markowitz L (2014) Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014—United States. Morb Mortal Wkly Rep 63(29):620–624Google Scholar
  40. 40.
    Kata A (2002) Anti-vaccine activists, Web 2.0, and the postmodern paradigm—an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine 30(25):3778–3789CrossRefGoogle Scholar
  41. 41.
    Pías-Peleteiro L, Cortés-Bordoy J, Martinón-Torres F (2013) Dr Google: what about the human papillomavirus vaccine? Hum Vaccin Immunother 9(8):1712–1719CrossRefGoogle Scholar
  42. 42.
    Dilley SE, Peral S, Straugh M, Scarinci I (2018) The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med 113:124–131CrossRefGoogle Scholar
  43. 43.
    Kepka D, Bodson J, Lai D, Sanchez-Birkead AS, Villalta J, Mukundente V, Tavake-Psi F, Davis FA, Lee D, Napia E, Mooney R, Coulter H, Stark LA (2018) Factors associated with human papillomavirus vaccination among diverse adolescents in a region with low human papillomavirus vaccination rates. Health Equity 2(1):223–232CrossRefGoogle Scholar

Copyright information

© American Association for Cancer Education 2019

Authors and Affiliations

  1. 1.College of Health SolutionsArizona State UniversityPhoenixUSA
  2. 2.University of Arizona College of MedicinePhoenixUSA
  3. 3.College of Health SolutionsArizona State UniversityPhoenixUSA

Personalised recommendations